The International Consortium for Health Outcomes Measurement (ICHOM), an independent non-profit organisation with offices in Cambridge, Massachusetts and London, England, has named physician-entrepreneur Dr Neil Bacon as its new president and CEO, effective immediately, it is reported today.
Dr Bacon succeeds Dr Christina Akerman, who has returned to her native Sweden after four years as president. Dr Bacon, a nephrologist trained at Oxford and Harvard, is a distinguished academic clinician and health information technology entrepreneur. He is internationally recognised leader in quality measurement and engaging patients in their health. Dr Bacon founded Doctors.net.uk in 1996. In recognition of his contributions utilising the Internet to improve healthcare, he was named a Fellow of the Royal College of Physicians in London in 2015. In 2008, Dr Bacon founded iWantGreatCare, an independent organisation enabling patients to rate and review their doctors, dentists, hospitals, after-care facilities, and medications where he was CEO. With reviews from more than five million patients in 23 countries, iWantGreatCare has become a powerful tool for driving health care improvement worldwide.
Harvard Business School professor Michael Porter, ICHOM co-founder and chairman of the board, said, 'Dr Neil Bacon is a pioneer and entrepreneur in use of information technology to enhance quality measurement and change health care. Universal measurement of outcomes that matter to patients, medical condition by medical condition, is the most powerful single tool to change health care.'
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign